All lobbying filings

THE PERSONAL CARE PRODUCTS COUNCIL

Lobbying for PERSONAL CARE PRODUCTS COUNCIL

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $120,000.00 expenses · posted Jan 20, 2026

Official filing document

Bills named in this filing 13

HR 2269
WIPPES Act
HR 2853
Combating Organized Retail Crime Act of 2025
S 1404
Combating Organized Retail Crime Act
HR 4433
Toxic-Free Beauty Act of 2025
HR 6832
PACK Act
HR 1657
Humane Cosmetics Act of 2025
HR 2821
FDA Modernization Act 3.0
S 355
FDA Modernization Act 3.0
S 2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
HR 4273
Over-the-Counter Monograph Drug User Fee Amendments
S 2292
Over-the-Counter Monograph Drug User Fee Amendments
HR 3686
SAFE Sunscreen Standards Act
HR 9747
Continuing Appropriations and Extensions Act, 2025

Lobbying activity 5

Consumer Issues/Safety/Products

SHOP SAFE Act (issues related to counterfeit cosmetic products); HR 2269/S 1092, WIPPES Act (product labeling for non-flushable wipes); H.R. 2853 / S. 1404,Combating Organized Retail Crime Act; H.R. 4433, Toxic-Free Beauty Act; H.R. 6832, Packaging and Claims Knowledge (PACK) Act of 2025.

Animals

HR 1657, Humane Cosmetics Act; H.R. 2821/S. 355, FDA Modernization Act 3.0 (issues related to animal-based testing for OTC products)

Budget/Appropriations

S. 2256, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 (cosmetic regulation funding issues); H.R. 9747 Continuing Appropriations and Extensions Act of 2025

Health Issues

H.R. 4273 / S.2292, Over-the-Counter Monograph User Fees Act (issues related to the OMUFA program); H.R. 3686, Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act

Tariff (miscellaneous tariff bills)

Section 301, Section 232 and IEEPA Tariffs; USMCA Review

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.